# Vorinostat Plus Radiation Therapy in Pancreatic Cancer

> **NCT00831493** · PHASE1,PHASE2 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 3 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **RADIATION:** Chemoradiation (Radiation Therapy)
- **DRUG:** Vorinostat

## Key facts

- **NCT ID:** NCT00831493
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-05
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Slow Accrual.
- **Last updated:** 2012-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00831493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00831493, "Vorinostat Plus Radiation Therapy in Pancreatic Cancer". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00831493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*